4TH ANNUAL BREAST CANCER SYMPOSIUM
30-Day on demand is available

This conference was held September 23-25, 2022.

Proudly Hosted By:

Fee INFORMATION

This activity is being offered free of charge. To be provided the login information, please register. An email will be sent to you with the login instructions.

Registration

BCS | Registration

First Name *

Last Name *

Degree * Degree

Specialty (for healthcare professionals)

Institution *

Phone *

Email *

How did you hear about us?

In Person or Online?

Program Overview

The 4th Annual Breast Cancer Symposium titled: OPENING DOORS: Lab to Clinic to Patient was organized in collaboration with New York Oncology Hematology (NYOH), The University of Chicago Pritzker School of Medicine, and myMedEd, Inc. This accredited conference offered 16.5 continuing education credits and was held September 23-25, 2022 at the Hudson Hall in Hudson, NY and as an online live broadcast.

CONFERENCE PLATFORM

The 4th Annual Breast Cancer Symposium was held live in person and online via a live broadcast.

Educational Goal

Advances in our understanding of the genetic and physiologic pathways of breast cancer have led to the development of targeted systemic therapies, improved surgical procedures, and radiation techniques, and improved, disease-free, and overall survival benefits. The goal of this conference is to educate the medical and global community in a forum that will facilitate the utilization of optimal treatment strategies and foster communication that will benefit the individual patient as well as the community.

TARGET AUDIENCE

Medical, surgical, and radiation oncologists as well as primary care physicians, gynecologists, medical professionals and health care professionals with an interest in breast cancer are invited to attend.

LEARNING OBJECTIVES

After completing this activity, participants will be able to:

Review the recent developments in breast surgical approaches including upfront and after neoadjuvant chemotherapy
Explain the rationale for reconstruction options post neoadjuvant chemotherapy and radiation therapy
Discuss updates in breast cancer imaging for earlier detection
Identify therapeutic advances in early and advanced hormone receptor-positive, HER2 neu overexpressing, and triple-negative breast cancer
Review the advances in radiation therapy and outcomes including short-course radiation therapy and de-escalation
Describe the management of HER2 positive early breast cancer in the older patient
Review the treatment of early-stage inherited breast cancer
Identify the new and emerging systemic treatment options for breast cancer brain metastases beyond surgery and radiotherapy
Describe molecular profiling for metastatic breast cancer management
Explain the mechanism of action and rationale for immunotherapy

DOWNLOAD AGENDA

Planning Committee

Maria Theodoulou, MD (Course Chair & Moderator)
Program Director
Breast Cancer Medicine
New York Oncology Hematology
Albany, NY

FACULTY

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
President and Director of Research, Sass Foundation for Medical Research
Lake Success, NY

Rakel Astorga MD
Breast and General Surgery
Albany Med Health System
Chief of Surgery
Columbia Memorial Hospital
Hudson, NY

Dr. Anna Boguniewicz M.D.
Associate Professor
Director, Pathology Residency Training Program
Department of Pathology and Laboratory Medicine
Albany Medical Center
Albany, NY

Dr. Edi Brogi M.D., Ph.D.
Director of Breast Pathology and Attending Pathologist
Memorial Sloan Kettering Cancer Center
Professor of Clinical Pathology and Laboratory Medicine
Weill Cornell Medical College
New York, NY

Hiram S Cody III, MD
Attending Surgeon
Breast Service, Department of Surgery
Memorial Sloan Kettering Cancer Center
Professor of Surgery
Weill Cornell Medical College
New York, NY

Rufus Collea, MD
Breast Oncology New York Oncology Hematology
Clinical Assistant Professor
Albany Medical Center
Medical Director
New York Oncology Hematology (NYOH)
Albany, NY

Chau T. Dang, MD
Medical Director, MSK Westchester Medical Oncology
Attending, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
New York, NY

Azeez Farooki, MD
Attending Physician
Endocrinology Service
Memorial Sloan Kettering Cancer Center
New York, NY

Monica Fornier, MD
Associate Member
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, NY

VK Gadi, MD, PhD
Professor and Director, Medical Oncology
Associate Director, Translational Medicine
University of Illinois Cancer Center
Chicago, IL

Yasmin Hasan, MD
Associate Professor
Department of Radiation and Cellular Biology
Residency Program Director
Director of Gynecological Brachytherapy
University of Chicago Medical Center
Chicago, IL

Claudine Isaacs, MD, FRCPC
Professor of Medicine and Oncology
Associate Director, Clinical Research
Leader, Clinical Breast Cancer Program
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

Neil Iyengar, MD
Associate Attending
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
Associate Attending
Rockefeller University
New York, NY

Monique C. James, MD
Assistant Attending Psychiatrist
Department of Psychiatry and Behavioral Sciences
Memorial Sloan Kettering Cancer Center
New York, NY

Kevin Kalinsky, MD, MS
Director, Glenn Family Breast Center
Winship Cancer Institute at Emory University
Atlanta, GA

Reshma Mahtani, DO (MCI)
Chief of Breast Medical Oncology
Miami Cancer Institute
Baptist Health South Florida
Plantation, FL

Terry P. Mamounas, MD, MPH, FACS
Medical Director, Comprehensive Breast Program
Orlando Health Cancer Institute
Professor of Surgery
University of Central Florida
Orlando, FL

Dr. Heather McArthur
Clinical Director of Breast Cancer and Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern
Dallas, TX

Beryl McCormick, MD, FACR
Attending Radiation Oncologist
Department of Radiation Oncology
Memorial Hospital
Professor of Radiology
Weill Cornell Medical School
New York, New York

Babak Mehrara, MD
Chief of Plastic and Reconstructive Surgery
Memorial Sloan Kettering Cancer Center
New York, NY

Shanu Modi, MD
Member and Attending
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, New York

Elizabeth Morris, MD
Professor and Chair of Radiology
University of California, Davis
Davis, CA

Hyman B. Muss, MD
Mary Jones Hudson Distinguished Professor of Geriatric Oncology
Professor of Medicine, University of North Carolina
Director of Geriatric Oncology, Lineberger Comprehensive Cancer Center
Chapel Hill, NC

Larry Norton, MD, FASCO, FAACR
Senior Vice President, Office of the President
Medical Director, Evelyn H. Lauder Breast Center
Deputy Director for Clinical and Translational Science, MSK Comprehensive Cancer Center
Norna S. Sarofim Chair of Clinical Oncology
New York, NY

Anne O’Dea, MD
Associate Professor, Breast Medical Oncology
Director, Breast Cancer Survivorship
University of Kansas School of Medicine
Kansas City, KS

Dr. Tia Olds, M.D.
Radiation Oncologist
New York Oncology Hematology
Albany, NY

Elizabeth Poynor, MD, PhD
Clinical Professor of Obstetrics and Gynecology
New York University, Langone
New York, New York

Andrew Seidman, MD
Attending Physician
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weil Cornell Medical College
New York, NY

Tiffany A. Traina, MD
Vice Chair, Oncology Care
Section Head, Triple Negative Breast Cancer Clinical Research Program
Associate Attending Physician
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Associate Professor
Weill Cornell Medical College
New York, NY

Maria Theodoulou, MD (Course Director)

Medical Oncologist

New York Oncology Hematology

Albany, NY

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
Lake Success, NY

Jeanne Carter, PhD
Head, Female Sexual Medicine and Women's Health Program
Memorial Sloan Kettering Cancer Center
New York, NY

Todd Doyle, MD
Director of Radiation Therapy
New York Oncology Hematology
Albany, NY

Download Agenda

Thank you to our Sponsors and Exhibitors:

GOLD SPONSORSHIP:
Pfizer Inc.

SILVER SPONSORSHIP:
Caris Life Sciences
Gilead Sciences, Inc
Novartis
Puma Biotechnology

BRONZE SPONSORSHIP:
Adaptive Biotechnologies
Agendia, Inc
BeiGene
Breast Cancer Index, BioTheranostics, Inc.
Daiichi Sankyo, Inc.
GE HealthCare
Genentech, Inc.
Incyte Corporation
Lilly USA, LLC
Merck & Co, Inc
NeoGenomics
Sanofi
Seagen, Inc.

Online Exhibit Application

Conference Organizers Contact Information:

1-800-973-0665
exhibits@mymededco.com

Download Support Opportunities

HOST

The 4th Annual Breast Cancer Symposium is proudly hosted by New York Oncology Hematology.

ACCREDITATION

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council of Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine, and New York Oncology Hematology, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Disclosure Declarations:
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.

The annual Breast Cancer Symposium brings together nationally and internationally known speakers, as well as our regional thought leaders on the holistic care of women with breast cancer. The agenda is delivered by an esteemed faculty in the breast cancer world, who continue to move forward with research from bench to clinic.

Click on the links below to view the programs from years past.

2019 Breast Cancer & Survivorship in the 21^st Century: Less is More, More or Less

2020 Controversies in Breast Cancer: Increasing or Decreasing?

2021 Seasons of Breast Cancer

2022 4th Annual Breast Cancer Symposium: Opening Doors: Lab to Clinic to Patient

Thank you to the collaborators, educational grant providers, sponsors and exhibitors, past and present, who have made this event possible: